Pronova Investor Odin Is Still Not ‘Satisfied’ With BASF Offer

Odin Forvaltning AS, which holds 4.7 percent of Pronova BioPharma ASA, said that it is still “not satisfied” with BASF SE’s higher offer for the Norwegian drug ingredient maker.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.